Ontology highlight
ABSTRACT:
SUBMITTER: Niespodziany I
PROVIDER: S-EPMC4359682 | biostudies-literature | 2015 Mar
REPOSITORIES: biostudies-literature
Niespodziany Isabelle I André Véronique Marie VM Leclère Nathalie N Hanon Etienne E Ghisdal Philippe P Wolff Christian C
CNS neuroscience & therapeutics 20141201 3
<h4>Aims</h4>Brivaracetam (BRV) is an antiepileptic drug in Phase III clinical development. BRV binds to synaptic vesicle 2A (SV2A) protein and is also suggested to inhibit voltage-gated sodium channels (VGSCs). To evaluate whether the effect of BRV on VGSCs represents a relevant mechanism participating in its antiepileptic properties, we explored the pharmacology of BRV on VGSCs in different cell systems and tested its efficacy at reducing the sustained repetitive firing (SRF).<h4>Methods</h4>B ...[more]